SLC19A2 and thiamine-responsive megaloblastic anemia syndrome: Carriers of homozygous or compound heterozygous loss-of-function or missense mutations in SLC19A2 develop a rare condition known as thiamine-responsive megaloblastic anemia (TRMA) or Rogers syndrome (OMIM 249270).